- Home
- MSEX vs CMRX Comparison
MSEX vs CMRX Comparison
Compare MSEX & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSEX
- CMRX
- Stock Information
- Founded
- MSEX 1897
- CMRX 2000
- Country
- MSEX United States
- CMRX United States
- Employees
- MSEX N/A
- CMRX N/A
- Industry
- MSEX Water Supply
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MSEX Utilities
- CMRX Health Care
- Exchange
- MSEX Nasdaq
- CMRX Nasdaq
- Market Cap
- MSEX 895.1M
- CMRX 797.3M
- IPO Year
- MSEX N/A
- CMRX 2013
- Fundamental
- Price
- MSEX $63.87
- CMRX $8.52
- Analyst Decision
- MSEX Hold
- CMRX Hold
- Analyst Count
- MSEX 3
- CMRX 4
- Target Price
- MSEX $59.33
- CMRX $8.51
- AVG Volume (30 Days)
- MSEX 251.2K
- CMRX 8.5M
- Earning Date
- MSEX 05-07-2025
- CMRX 03-21-2025
- Dividend Yield
- MSEX 2.13%
- CMRX N/A
- EPS Growth
- MSEX 39.94
- CMRX N/A
- EPS
- MSEX 2.47
- CMRX N/A
- Revenue
- MSEX $191,877,000.00
- CMRX $212,000.00
- Revenue This Year
- MSEX $10.20
- CMRX $2,685.38
- Revenue Next Year
- MSEX $6.56
- CMRX $1,050.23
- P/E Ratio
- MSEX $25.88
- CMRX N/A
- Revenue Growth
- MSEX 15.40
- CMRX N/A
- 52 Week Low
- MSEX $45.42
- CMRX $0.75
- 52 Week High
- MSEX $70.73
- CMRX $8.53
- Technical
- Relative Strength Index (RSI)
- MSEX 67.03
- CMRX 83.28
- Support Level
- MSEX $59.07
- CMRX $8.41
- Resistance Level
- MSEX $64.97
- CMRX $8.52
- Average True Range (ATR)
- MSEX 1.60
- CMRX 0.02
- MACD
- MSEX 0.03
- CMRX -0.15
- Stochastic Oscillator
- MSEX 81.36
- CMRX 85.72
About MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.